FirstTake on Pharma - Pharma News and Analysis Podcast podcast

The FirstTake Podcast – Where next for gene editing?

0:00
11:39
Manda indietro di 15 secondi
Manda avanti di 15 secondi
On this week’s episode FirstWord Pharma PLUS editors Virginia Li, Michael Flanagan and Simon King discuss key developments in the field of gene editing, the approval of Janssen and Legend Biotech’s Carvykti for multiple myeloma and whether interchangeability status will have a meaningful impact on future US market for Humira biosimilars.

Altri episodi di "FirstTake on Pharma - Pharma News and Analysis Podcast"